Conventional chemotherapy targets rapidly dividing cells in an effort to block cancer's growth.
http://scopeblog.stanford.edu/2013/02/04/gleevec-resistant-tumors-respond-to-antibody-treatment-in-mice/?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+stanford%2Fscope+%28SCOPE%29
http://scopeblog.stanford.edu/2013/02/04/gleevec-resistant-tumors-respond-to-antibody-treatment-in-mice/?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+stanford%2Fscope+%28SCOPE%29
No comments:
Post a Comment